Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.

The new Medicare GLP-1 Bridge program, which will allow seniors to get certain GLP-1 drugs for just $50 a month and is part ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...

(NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that Weight Watchers Med+ will support Medicare members seeking access to GLP-1 medications under ...

Pharmacists can help answer questions about eligibility requirements, participating medications, prior authorization ...

Weight Watchers said Tuesday that its Med+ platform will help eligible Medicare beneficiaries access GLP-1 weight-loss drugs through the new Medicare GLP-1 Bridge Program. The program, which runs from ...

Form Health, the national leader in science-based obesity and cardiometabolic care, today announced it has begun prescribing through the new Medicare GLP-1 Bridge Program, a new demonstration program ...